C
ChemT
Founded in 2024 by Jie Sun and Dr. Ling Wu, ChemT provides an AI-powered platform called CelMo, which acts as a virtual cell model. By simulating how cells respond to manufacturing conditions and genetic modifications, the company helps pharmaceutical manufacturers improve productivity and scalability in biologics production.
Funding
Every round, secondary, debt facility or acquisition involving ChemT that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see every AI company on Lounge with revenue, funding, valuation and investors, searchable and sortable, plus CSV exports. Plans start at $19/mo.
See plans →Log in